| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8579402 | Pediatria Polska | 2017 | 6 Pages |
Abstract
The occurrence of neurological disorders is influenced by the degree of immunodeficiency, HIV viral load at diagnosis, and age of initiation of ARV therapy. Starting ARV treatment <12 months of age has a neuroprotective effect.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Urszula Coupland, Magdalena MarczyÅska,